Tirzepatide

Yes. Tirzepatide is a 39-amino-acid synthetic peptide with a C20 fatty diacid chain that enables albumin binding and extended stability, which is why it is a popular subject in peptide pharmacology studies.

Tirzepatide binds and activates two separate incretin receptors, GIP and GLP-1, simultaneously. This dual mechanism is the focus of research into glucose homeostasis, insulin signaling, and appetite regulation pathways.

Semaglutide is a single GLP-1 receptor agonist, while Tirzepatide is a dual GIP/GLP-1 agonist. Researchers study Tirzepatide specifically to compare single-receptor versus dual-receptor activation in metabolic models.

This Tirzepatide is ≥99% pure, verified by third-party HPLC and LC-MS testing. A batch-specific Certificate of Analysis (COA) documents purity, identity, and mass for full traceability.

Lyophilized Tirzepatide should be stored sealed at -20°C, protected from light and moisture. After reconstitution, it should be kept refrigerated and used within the timeframe indicated by your research protocol.

Yes. Every batch ships with a Certificate of Analysis from independent laboratory testing, confirming the compound meets the stated 99%+ purity standard for research applications.

It is used in laboratory research on metabolic regulation, incretin biology, receptor signaling, glucose metabolism, and body composition models. It is strictly for in-vitro and non-human research use only.